Status
Conditions
Treatments
About
The goal of this study is to develop a new internet-delivered cognitive behavioral therapy (ICBT) intervention for youths with anxiety disorders based on the best current knowledge about effective cognitive behavioral therapy for the target group, refine the intervention in collaboration with patient and public representatives, and conduct a preliminary evaluation of the treatment effects in an open clinical trial.
The primary objective of the study is:
Secondary objectives of the study are:
Participants will:
Full description
A detailed description is available in the full study protocol. All full study protocol versions may be accessed at the Open Science Framework (https://osf.io/fdnga/).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Confirmed by the child/caregiver and subsequently by the medical record system. 2) A principal DSM-5-TR anxiety disorder of specific phobia, separation anxiety disorder, social anxiety disorder, generalized anxiety disorder, panic disorder or agoraphobia.
Confirmed by the Diagnostic Interview for Anxiety, Mood, and OCD and related Neuropsychiatric Disorders - Child and Adolescent Version (DIAMOND-KID).
Confirmed by the child/caregiver. 4) An available caregiver who can support the child in treatment.
Confirmed by the caregiver. 5) Access to a smartphone, tablet, or laptop/desktop device, and the internet.
Confirmed by the child/caregiver.
Exclusion criteria
Confirmed by a blood-injection-injury phobia being classified as the principal anxiety disorder as assessed by the DIAMOND-KID.
Confirmed by the caregiver (through previous diagnosis) and/or by attending a special needs school for learning difficulties.
According to the DIAMOND-KID and/or other available sources. 4) Social/familial/educational difficulties in more immediate need of management than an anxiety disorder.
Confirmed by the assessor through information from the child/caregiver and/or other available sources.
Confirmed by the assessor through information from the child/caregiver and other available sources.
Confirmed by the child/caregiver or the medical record system. 7) Ongoing psychological treatment for an anxiety disorder.
Confirmed by the child/caregiver or the medical record system. 8) Initiation or adjustment of any psychotropic medication for anxiety (i.e., selective serotonin reuptake inhibitors, tricyclic antidepressants, serotonin-norepinephrine reuptake inhibitor or antipsychotics) within 8 weeks prior to assessment.
Confirmed by the child/caregiver or the medical record system. 9) Participation in user involvement sessions in the present study.
Confirmed by the researcher.
Primary purpose
Allocation
Interventional model
Masking
48 participants in 1 patient group
Loading...
Central trial contact
Per Andrén, PhD; Eva Serlachius, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal